Primary care-based liver health trial commencing in 2024

A multidisciplinary team of researchers including Professor Leon Adams (University of Western Australia) and our own leading GP researcher Professor Jon Emery (Department of General Practice and Primary Care, University of Melbourne), will lead IDEAL Care. This is an innovative trial in partnership with urban and rural general practices across Western Australia and Victoria to test the real-world effectiveness of an integrated general practice-based diagnostic pathway to detect advanced liver fibrosis in the community.

“We are optimistic that this integrated pathway will show promise and opportunities for treatment and preventative care including liver cancer surveillance,” said Rachel Brooks, National Manager of the IDEAL Care Trial.

Outcomes from this study will provide the evidence to introduce clinical pathways to identify at-risk patients who may benefit from specialist review and avoid needless referral for those not at risk. As the intervention is designed to consist of current and available technologies incorporated into existing software platforms, the research team anticipate that the implementation of findings will be rapid.

The research team will seek to work with 24 general practices across metropolitan, regional and rural Victoria to test this innovative digital intervention. GPs across collaborating practices will have the opportunity to participate in a CPD education module and each practice will be re-imbursed $1500.

For further information, please contact:

Rachel Brooks (National Manager of the IDEAL Care Trial):  brooks.r@unimelb.edu.au

VicREN: vicren-enquiries@unimelb.edu.au

The IDEAL Care Trial has received funding under the Australian Government’s Medical Research Future Fund (MRFF).

More Information

Rachel Brooks, National Manager

brooks.r@unimelb.edu.au

+61 3 8344 3392